Plain-English translation of NCT06546670 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a clinical trial testing a new medication called to see if it is safe and works well for people with sickle cell disease. The trial will first test the medication in healthy volunteers to make sure it is safe, and then test it in patients who actually have sickle cell disease. Researchers want to understand how the medication works in the body and whether it can help reduce symptoms and complications of the disease.
Sickle cell disease is a serious blood disorder that causes pain, organ damage, and other serious health problems. Current treatment options are limited, so researchers are testing this new medication to see if it offers patients another way to manage their condition and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
The trial has two main parts. First, healthy volunteers will take the medication and have their blood tested and heart monitored to make sure it is safe. Then, patients with sickle cell disease will take the medication and visit the clinic regularly so doctors can check if it is working and watch for any side effects. The exact length and number of visits will depend on which part of the trial you join, but you can expect multiple clinic visits over several months.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States